Antibiotic Resistance Related Content

Bacteria are often painted as the enemy of humanity. Before the discovery of antibiotics, a wound getting infected was frequently a death sentence.

Reflecting on the recent World Antimicrobial Awareness Week (WAAW 2022), it’s evident that we must continue to raise better awareness and understanding of antimicrobial resistance, which is one of the top 10 global public health threats facing humanity.

Research on antibiotic resistance, specifically looking at gene-swapping systems in bacteria, has been awarded €2.5 million from the European Research Council.

Here, several academic experts explain what we need to know about removing the blindfold on antimicrobial resistance - by strengthening clinical microbiology laboratories in resource-limited settings.

Dr Zisis Kozlakidis & Prof Olivier Vandenberg, describe the challenges of clinical microbiology in resource-restricted settings

Dr Michel Gasana & Dr Hugues Lago from WHO - Regional Office for Africa, spoke to OAG about the status of tuberculosis prevention

According to a new study in The Lancet, antimicrobial resistance is now a leading cause of death worldwide, higher than HIV/AIDS or malaria.

A study finds that broad-spectrum antibiotics are prescribed due to a lack of resources for GPs - with "time-consuming microbiological tests" taking too long.

Roxane Feller, AnimalhealthEurope Secretary-General, tells us all about the new EU rules on veterinary medicines to support more responsible use of antibiotics.

Researchers at KU Leuven have discovered that certain antibiotics appear to be effective in treating a form of skin cancer known as melanoma.

In Bangladesh, children are fighting a difficult battle to survive antibiotic resistance - now, mid-pandemic, pneumonia is becoming untreatable via normal drugs.

A new study confirms that antimicrobial resistance increases as people travel internationally, with one scientist commenting that the world faces "a worrisome problem on the horizon".

Named after a freedom fighter who spoke up for science and tech, a group of African and international research funders under the OR Tambo Africa Research Chairs Initiative announced Prof Gerald Misinzo and his institution Sokoine University of Agriculture as one of the initiative’s first ten individual research chair holders and host institutions.

There is a well-established diphtheria vaccine taken by millions of people, but researchers are now observing the disease evolving a resistance to antimicrobial treatment.

The PRINCIPLE trial has found that azithromycin and doxycycline do not provide any recovery benefits for COVID-19 patients.

Researchers have developed a DNA test to rapidly identify pneumonia in COVID-19 patients, aiding faster treatment.

SACIDS Africa Centre of Excellence for Infectious Diseases trains young African scientists in research on global health issues: An example of a PhD Student Research on antimicrobial resistance (AMR).

Chris Wakefield, Vice President of GOJO Industries-Europe Ltd, explores how businesses can navigate the increase in cleaning products on the market and select products that will best meet their needs.

Rex Clements, CEO at Centrient Pharmaceuticals, discusses how the upcoming EU Pharma Strategy can prevent shortages and strengthen Europe’s manufacturing base, especially for antibiotics.

Here, SACIDS Foundation for One Health discuss the volatile changing epidemics landscape in Africa.